Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,668 | 37,054 | 42,666 | 34,737 | 40,706 |
| Receivables | 224 | 228 | 267 | 162 | 384 |
| Inventories | 47 | 59 | 72 | 79 | 85 |
| Other current assets | 0 | 0 | 0 | 72 | 180 |
| TOTAL | $32,478 | $37,762 | $43,343 | $35,912 | $42,412 |
| Non-Current Assets | |||||
| PPE Net | 1,076 | 1,029 | 988 | 1,084 | 977 |
| Intangibles | 8,710 | 8,934 | 9,154 | 9,582 | 9,955 |
| TOTAL | $9,786 | $9,963 | $10,141 | $10,666 | $10,932 |
| Total Assets | $42,264 | $47,725 | $53,485 | $46,578 | $53,344 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 592 | 258 | 1,130 | 873 | 613 |
| Accrued Expenses | 2,886 | 3,120 | 2,733 | 2,414 | 2,815 |
| TOTAL | $5,114 | $5,027 | $5,523 | $4,960 | $5,175 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,636 | 1,648 | 1,660 | 1,623 | 1,623 |
| TOTAL | $1,924 | $2,309 | $2,693 | $3,078 | $3,463 |
| Total Liabilities | $7,038 | $7,335 | $8,216 | $8,038 | $8,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 336 | 336 | 336 | 336 | 319 |
| Common Shares | 61 | 61 | 60 | 57 | 57 |
| Retained earnings | -188,151 | -182,987 | -178,073 | -171,218 | -164,994 |
| TOTAL | $35,226 | $40,390 | $45,269 | $38,540 | $44,706 |
| Total Liabilities And Equity | $42,264 | $47,725 | $53,485 | $46,578 | $53,344 |